AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Modigliani and Miller Proposition II
Highlights,The cost of equity increases as the firm's debt-to-equity ratio rises.,Higher debt raises financial risk, making equity holders demand higher returns.,The overall cost of capital remains unchanged in a perfect market.,Detailed Explanation,Modig...
- April 01, 2025 05:43 AM PDT
- Team Kalkine Media
Global Market Overview: APAC Recovery, US Tariffs, and Key Economic Releases Morning Wrap (01.04.2025)
Highlights:,APAC markets are showing signs of stability, with key indices recovering after previous losses.,The US Treasury Secretary confirmed the next round of tariffs will be announced soon, impacting global trade sentiment.,Key economic data releases,...
- April 01, 2025 05:36 AM PDT
- Team Kalkine Media
UBS Cuts S&P 500 Target to 6,400, Sees 15% Rally Still Possible
April 1 - UBS (NYSE:UBS) lowered its year-end target for the S&P 500 from 6,600 to 6,400, citing heightened volatility and economic uncertainty due to ongoing tariff measures. The bank noted that near...
- April 01, 2025 05:25 AM PDT
- EODHD
UBS Unveils Top 30 Stock Picks Across All S&P Sectors
April 1 - UBS's CIO Americas wealth management team has spotlighted its top thirty picks from the S&P sectors as Q1 2025 wraps up. The report highlights familiar names investors know well. Among the s...
- April 01, 2025 05:23 AM PDT
- EODHD
Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-...
- April 01, 2025 05:01 AM PDT
- EODHD
Nkarta to Participate in an April Investor Conference
SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its p...
- April 01, 2025 05:01 AM PDT
- EODHD
Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference
HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for t...
- April 01, 2025 05:00 AM PDT
- EODHD
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
DUBLIN, April 01, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of...
- April 01, 2025 05:00 AM PDT
- EODHD
electroCore to Participate at the Needham Virtual Healthcare Conference
ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at...
- April 01, 2025 05:00 AM PDT
- EODHD
Dynatrace Signs New Strategic Collaboration Agreement with AWS to Optimize the Digital Enterprise
Will provide joint customers with enhanced access to Dynatrace platform capabilities to help transform the complexity of modern digital ecosystems into powerful business assets WALTHAM, Mass., April 0...
- April 01, 2025 05:00 AM PDT
- EODHD